L2 Asset Management, LLC

Position in MRK — Merck & Co., Inc.

CIK 1686988 Wayland, MA

Position in MRK

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$1,138,638

-$558,052 QoQ

Shares Held

8,861

-37.2% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.16%

of 13F equity value

Holder Rank

#2,009

of 3,769 holders

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

L2 Asset Management, LLC holds $26,468,691 across 6 Drug Manufacturers - General names. MRK ranks #5 (4.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AMGN	Amgen Inc	31,241	$11,312,990
2	GILD	Gilead Sciences, Inc.	64,505	$8,149,561
3	BMY	Bristol Myers Squibb Co	45,073	$2,597,106
4	ABBV	AbbVie Inc.	9,799	$2,465,820
5	MRK	Merck & Co., Inc. This page	8,861	$1,138,638
6	JNJ	Johnson & Johnson	3,168	$804,576

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,138,638	8,861	-37.2%	Shares	Sole	2026-08-13
2026-03-31	$1,696,690	14,105	-22.1%	Shares	Sole	2026-05-15
2025-12-31	$1,905,627	18,104	+12.8%	Shares	Sole	2026-02-17
2025-09-30	$1,346,824	16,047	+121.8%	Shares	Sole	2025-11-14
2025-06-30	$572,722	7,235	+20.2%	Shares	Sole	2025-08-14
2025-03-31	$540,355	6,020	+5.9%	Shares	Sole	2025-05-15
2024-03-31	$750,399	5,687	+39.0%	Shares	Sole	2024-05-15
2023-12-31	$446,000	4,091	+6006.0%	Shares	Sole	2024-02-13
2023-09-30	$6,897	67	-99.4%	Shares	Sole	2023-11-08
2023-06-30	$1,248,404	10,819	+13.8%	Shares	Sole	2023-08-11
2023-03-31	$1,011,662	9,509	+187.1%	Shares	Sole	2023-05-12
2022-12-31	$367,466	3,312	0.0%	Shares	Sole	2023-02-14
2022-09-30	$285,229	3,312	-42.9%	Shares	Sole	2022-11-14
2020-03-31	$446,328	5,801	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.